NYSE:MCDHospitality
McDonald's Tests GLP-1 Friendly Menu While Deepening Cultural Relevance
McDonald's (NYSE:MCD) is reworking its menu to appeal to Americans using GLP-1 weight loss drugs, including tests of higher protein options.
The company is also rolling out fresh marketing tie ups, such as the Drake OVO Afters Meal in Canada, to keep its brand culturally visible.
For a company built on burgers, fries and soft drinks, McDonald's sits at the center of changing food habits and health trends. GLP-1 medications are starting to influence how some consumers think about portions,...